MacroGenics Inc
-
Ticker
MGNX
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 201-500 Employees
- Based in Rockville, Maryland
MacroGenics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as autoimmune disorders and infectious diseases. The company generates its pipeline of product candidates from its proprietary suite of next-generation antibody-based technology platforms.
MacroGenics Inc
Most Recent Responsibility Report
MOST RECENT
2023 Corporate Responsibility Report
Report Locked. MacroGenics Inc has reached its limit for free report views.
Our service enables potential investors to review the most recent and archived MacroGenics Inc Sustainability Report, MacroGenics Inc Corporate Social Responsibility Report, MacroGenics Inc CSR Report, MacroGenics Inc Corporate Responsibility, MacroGenics Inc CR Report, MacroGenics Inc Citizenship Report, MacroGenics Inc ESG Report, and MacroGenics Inc Environmental Report online.